Showing results (321-330 of 369) with videos related to
Sort By:
Pageof 37
International Journal of Radiation Oncology, Biology, Physics|December 28, 2020
Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic CancerAnand Mahadevan, Shalini Moningi, Jimm Grimm, et al.Nature|November 9, 2013
Large contribution of natural aerosols to uncertainty in indirect forcingK S Carslaw, L A Lee, C L Reddington, et al.Cardiovascular Research|October 3, 2022
Vascular calcification maladaptively participates in acute phosphate homeostasisMandy E Turner, Tyler S Rowsell, Austin P Lansing, et al.Anti-Cancer Drugs|January 25, 2003
Assessment of epidermal growth factor receptor with 99mTc-ethylenedicysteine-C225 monoclonal antibodyNaomi R Schechter, David J Yang, Ali Azhdarinia, et al.British Journal of Pharmacology|February 9, 2017
Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 receptor agonist LY2934747, in rodent pain modelsMichael P Johnson, Mark A Muhlhauser, Eric S Nisenbaum, et al.ACS Macro Letters|February 6, 2026
Control of Dynamic Composites through Filler Surface ChemistryNeil D Dolinski, Lily Alperstein, Ran Tao, et al.The British Journal of Ophthalmology|October 22, 2015
Diabetes and diabetic retinopathy in people aged 50 years and older in the Republic of SurinameJanna Minderhoud, Jerrel C Pawiroredjo, Anne-Marie T Bueno de Mesquita-Voigt, et al.ACS Applied Materials & Interfaces|January 22, 2016
Lightweight, Flexible, High-Performance Carbon Nanotube Cables Made by Scalable Flow CoatingFrancesca Mirri, Nathan D Orloff, Aaron M Forster, et al.International Journal of Radiation Oncology, Biology, Physics|May 1, 2007
Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesotheliomaDavid C Rice, W Roy Smythe, Zhongxing Liao, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Antitumor activity of lurbinectedin (PM01183) and doxorubicin in relapsed small-cell lung cancer: results from a phase I studyE Calvo, V Moreno, M Flynn, et al.Pageof 37